Times are displayed in (UTC-06:00) Central Time (US & Canada) Change
5/4/2024 | 11:30 AM – 12:45 PM | Exhibit Hall F1
Poster Session—Advances in T Cell Profiling and Viral Targeting (AM)
Development of single-cell ROS regulome profiles of CD8+ T cells
(P807)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 807
Abstract ID: 4174
Presenting Author:
YI-CHUAN WANG, Stanford Univ.
View Abstract Details
Evaluation of a human peripheral blood NK humanized hIL-15 mouse model lacking murine Fc gamma receptors
(P811)
Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 811
Abstract ID: 4397
Presenting Author:
Philip Dubé, Taconic Biosciences, Inc.
Co-Authors:
Nicholas Smith, Taconic Biosciences, Inc.; Monika Buczek, Taconic Biosciences, Inc.; Megan MacBride, Taconic Biosciences, Inc.; Esther Andino, Taconic Biosciences, Inc.; Emily Sack, Taconic Biosciences, Inc.; Debra Freer, Taconic Biosciences, Inc.; Michelle Vedder, Taconic Biosciences, Inc.; Kathleen Bott, Taconic Biosciences, Inc.; Louise Baskin, Taconic Biosciences, Inc.; Janell Richardson, Taconic Biosciences, Inc.;
View Abstract Details
Jchain-diphtheria toxin receptor mice: a new tool allowing for the acute depletion of antibody-secreting cells.
(P813)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 813
Abstract ID: 4426
Presenting Author:
Peter Pioli, Univ. of Saskatchewan
Co-Author:
KimAnh Pioli, Univ. of Saskatchewan;
View Abstract Details
Diversity and affinity from plasma vs. B cells for monoclonal antibody development
(P815)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 815
Abstract ID: 4543
Presenting Author:
David Hawksworth, Abbott Laboratories
Co-Authors:
Jeff Moore, Abbott Laboratories; Isaac Larkin, Abbott Laboratories;
View Abstract Details
Evaluation of an IgG therapeutic efficacy in a humanized immune system mouse model lacking murine Fc gamma receptors
(P817)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 817
Abstract ID: 4677
Presenting Author:
Louise Baskin, Taconic Biosciences, Inc.
Co-Authors:
Nicholas Smith, Taconic Biosciences, Inc.; Monika Buczek, Taconic Biosciences, Inc.; Megan MacBride, Taconic Biosciences, Inc.; Esther Andino, Taconic Biosciences, Inc.; Emily Sack, Taconic Biosciences, Inc.; Debra Freer, Taconic Biosciences, Inc.; Michelle Vedder, Taconic Biosciences, Inc.; Kathleen Bott, Taconic Biosciences, Inc.; Janelle Richardson, Taconic Biosciences, Inc.;
View Abstract Details
Human Immune repertoire and gene expression in pediatric and adult SARS-CoV-2 infected patients using single cell multi-omics approaches
(P819)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 819
Abstract ID: 4847
Presenting Author:
xuhuai ji, Stanford Univ. Sch. of Med.
Co-Authors:
Lael M Yonker, Massachusetts Gen. Hosp., Harvard Med. Sch.; Molly Miranda, Stanford Univ. Sch. of Med.; Thomas Bernard Kinane, Massachusetts Gen. Hosp., Harvard Med. Sch.; Matthew Chang, BD BioSci.; Sundari Suresh, Stanford Univ. Sch. of Med.; Samaneh Kiany, Stanford Univ. Sch. of Med.; Katja Weinacht, Stanford Univ. Sch. of Med.; Holden T Maecker, Stanford Univ. Sch. of Med.;
View Abstract Details
Homogeneous bioluminescent immunoassays detect profound synergistic regulation of IL-8 and MCP-1 release in cultured human monocytes
(P821)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 821
Abstract ID: 4908
Presenting Author:
Dan F Lazar, Promega Corp.
Co-Authors:
Cassidy B Ames, Promega Corp.; Paula M Sequeira, Promega Corp.; Kevin R. Kupcho, Promega Corp.; Daniel Mamott, Promega Corp.; Martha A O'Brien, Promega Corp.; Sarah D Mahan, Promega Corp.; James J Cali, Promega Corp.;
View Abstract Details
Assessment of SARS-CoV-2 Spike and NCAP antigen-specific memory B cell frequency and Ig class/subclass usage following natural infection and/or COVID-19 mRNA vaccination
(P823)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 823
Abstract ID: 4920
Presenting Author:
Greg A Kirchenbaum, Cellular Technol., Northumbria Univ.
Co-Authors:
Noemi Becza, Cellular Technol.; Lingling Yao, Cellular Technol.; Zhigang Liu, Cellular Technol.; Jack Chepke, Cellular Technol.; Paul V Lehman, Cellular Technol.;
View Abstract Details
Virus-targeted self-attenuated influenza vaccine as an effective therapy against influenza
(P825)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 825
Abstract ID: 5253
Presenting Author:
Mingtao Zeng, Texas Tech Univ. Hlth. Sci. Ctr. El Paso
Co-Authors:
Yanping Chen, Texas Tech Univ. Hlth. Sci. Ctr. El Paso; Alejandra Munoz, Texas Tech Univ. Hlth. Sci. Ctr.; Yanru Qin, Texas Tech Univ. Hlth. Sci. Ctr. El Paso;
View Abstract Details
Utilizing a surgical resection model for evaluating mRNA-based multi-antigen targeting CAR-T cell therapy against solid tumors
(P827)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 827
Abstract ID: 5450
Presenting Author:
Oula K. Dagher, Univ. of Pennsylvania Perelman Sch. of Med.
Co-Author:
Avery D. Posey, Univ. of Pennsylvania Perelman Sch. of Med.;
View Abstract Details
Immune dynamics in response to risk group 4 pathogens in nonhuman primate models
(P829)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 829
Abstract ID: 5582
Presenting Author:
Deja FP Rivera, NIAID, DCR, IRF-Frederick, NIH
Co-Authors:
Bobbi Barr, NIAID, DCR, IRF-Frederick, NIH; Anthony E Marketon, NIAID, DCR, IRF-Frederick, NIH; Rebecca M Bernbaum-Culter, NIAID, DCR, IRF-Frederick, NIH; Bapi Pahar, NIAID, DCR, IRF-Frederick, NIH; Scott M Anthony, NIAID, DCR, IRF-Frederick, NIH;
View Abstract Details
Cellular immune responses in the guinea pig model with a 9-color phenotypic flow cytometry panel
(P831)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 831
Abstract ID: 5954
Presenting Author:
Scott M. Anthony, NIAID, DCR, IRF-Frederick, NIH
Co-Authors:
Anthony E Marketon, NIAID, DCR, IRF-Frederick, NIH; Bapi Pahar, NIAID, DCR, IRF-Frederick, NIH; Deja F.P. Rivera, NIAID, DCR, IRF-Frederick, NIH; Bobbi Barr, NIAID, DCR, IRF-Frederick, NIH; Rebecca M. Bernbaum-Cutler, NIAID, DCR, IRF-Frederick, NIH; Peter Caravan, Martinos Ctr. for Biomed. Imaging; Juan Carlos de la Torre, Scripps Res.; Venkatesh Mani, NIAID, DCR, IRF-Frederick, NIH; Brian D. Carey, NIAID, DCR, IRF-Frederick, NIH;
View Abstract Details
Selective targeting of cytotoxic effector CD8+ T cells via CX3CL1-conjugated mRNA lipid nanoparticles
(P833)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 833
Abstract ID: 6007
Presenting Author:
Angela R Corrigan, Univ. of Pennsylvania Perelman Sch. of Med.
Co-Authors:
Shin Ngiow, Univ. of Pennsylvania Perelman Sch. of Med.; Maria Betina Pampena, Univ. of Pennsylvania Perelman Sch. of Med.; Amie Albertus, Univ. of Pennsylvania Perelman Sch. of Med.; Houping Ni, Univ. of Pennsylvania Perelman Sch. of Med.; Vincent H Wu, Univ. of Pennsylvania Perelman Sch. of Med.; Edward Kreider, Univ. of Pennsylvania Perelman Sch. of Med.; E. John Wherry, Univ. of Pennsylvania Perelman Sch. of Med.; Drew Weissman, Univ. of Pennsylvania Perelman Sch. of Med.; Michael R Betts, Univ. of Pennsylvania Perelman Sch. of Med.;
View Abstract Details